
Mak Lung Yi
麥龍兒
DEPT
Department of Medicine
FACULTY
Li Ka Shing Faculty of Medicine
COVID-19 Contribution
Showing 1 - 5 out of 5
Show
20
Relevance
18 Jun 2021
Background and Aims: In the current era of highly effective direct acting antiviral (DAA) therapy, the one of the remaining obstacles to elimination o...Read more
14 Jul 2023
Elevations in alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were reported as adverse events of nirmatrelvir/ritonavir users in t...Read more
11 May 2022
01 Jul 2022
Background and Aim: To investigate and quantify the risks of AKI and ALI associated with remdesivir use, given the underlying diseases of SARS-CoV-2 i...Read more
01 Nov 2022
Background Case reports of severe acute liver injury (ALI) following COVID-19 vaccination are recently described. We evaluated the risks of ALI follo...Read more